ACC 2015:将发布22项临床试验结果

2015-03-14 MedSci 医学论坛网

全球心血管医生的学术盛会——美国心脏病学会年会(ACC 2015)将于3月14~16日在美国圣迭戈召开。本次大会共发布22项最新临床研究(Late-Breaking Clinical Trials)! PROMISE研究 稳定型冠心病患者的无创评估一直是心血管研究的热点,然而,目前并无相关大规模临床试验对这些评估策略进行比较. PROMISE研究是一项前瞻性的随机临床试验对两种冠心病

全球心血管医生的学术盛会——美国心脏病学会年会(ACC 2015)将于3月14~16日在美国圣迭戈召开。本次大会共发布22项最新临床研究(Late-Breaking Clinical Trials)!

PROMISE研究

稳定型冠心病患者的无创评估一直是心血管研究的热点,然而,目前并无相关大规模临床试验对这些评估策略进行比较.

PROMISE研究是一项前瞻性的随机临床试验对两种冠心病的无创评估策略进行比较:一是功能评估策略(包括运动心电图,负荷超声心动图以及负荷核素检查);另一种是解剖评估策略(64层螺旋CT冠脉造影)。所有病人至少随访一年,事件终点是死亡、非致死性心梗及主要并发症(包括卒中、大出血、肾衰),或者是因不稳定心绞痛住院。

目前,ACC/AHA的稳定性冠心病指南对于稳定性冠心病的筛查,其中可以进行运动的患者,运动心电图是I级推荐(证据级别A),心电图无法分析的患者运动核素及运动超声为I级推荐(证据级别B),而这部分患者CCTA检查是II级推荐(证据级别为B);对于无法运动的患者,药物负荷超声心动图及负荷核素检查均为I级推荐(证据级别是B),这部分患者CCTA检查为IIb级推荐(证据级别C)。这些指南的推荐也反映了目前稳定冠心病的诊断流程。

今年ACC开幕式上PROMISE研究的发布,会不会改变指南的策略选择呢?我们敬请期待!

其他公布的最新临床试验

PROMISE:比较解剖与功能策略的诊断试验对疑似CAD患者的差异

SCOT-HEART:CT冠脉成像在疑似冠心病心绞痛患者中的价值

PROMISE再分析:解剖诊断和功能诊断对有症状可疑冠心病者的经济成本

OSLER-1和-2:PCSK9抑制剂对心血管结局的影响

LEGACY:目标定向的体重管理对房颤患者的5年随访结果
BEST:依维莫司洗脱支架和冠脉旁路移植对多支病变冠心病患者的区别 

Total:血栓抽吸联合PCI与单独PCI对直接PCI患者的区别

经桡动脉途径和经股动脉途径对接受有创治疗ACS患者出血事件的影响

比伐卢定和普通肝素对接受有创治疗ACS患者出血事件的影响

多支病变的直接PCI策略:STEMI患者急性期策略探讨

相关文献:

Douglas PS, Hoffmann U, Lee KL, Mark DB, Al-Khalidi HR, Anstrom K, Dolor RJ, Kosinski A, Krucoff MW, Mudrick DW, Patel MR, Picard MH, Udelson JE, Velazquez EJ, Cooper L; PROMISEinvestigators.PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of thePROMISE trial. Am Heart J. 2014 Jun;167(6):796-803.

Newby DE1, Williams MC, Flapan AD, Forbes JF, Hargreaves AD, Leslie SJ, Lewis SC, McKillop G, McLean S, Reid JH, Sprat JC, Uren NG, van Beek EJ, Boon NA, Clark L, Craig P, Flather MD, McCormack C, Roditi G, Timmis AD, Krishan A, Donaldson G, Fotheringham M, Hall FJ, Neary P, Cram L, Perkins S, Taylor F, Eteiba H, Rae AP, Robb K, Barrie D, Bissett K, Dawson A, Dundas S, Fogarty Y, Ramkumar PG, Houston GJ, Letham D, O'Neill L, Pringle SD, Ritchie V, Sudarshan T, Weir-McCall J, Cormack A, Findlay IN, Hood S, Murphy C, Peat E, Allen B, Baird A, Bertram D, Brian D, Cowan A, Cruden NL, Dweck MR, Flint L, Fyfe S, Keanie C, MacGillivray TJ, Maclachlan DS, MacLeod M, Mirsadraee S, Morrison A, Mills NL, Minns FC, Phillips A, Queripel LJ, Weir NW, Bett F, Divers F, Fairley K, Jacob AJ, Keegan E, White T, Gemmill J, Henry M, McGowan J, Dinnel L, Francis CM, Sandeman D, Yerramasu A, Berry C, Boylan H, Brown A, Duffy K, Frood A, Johnstone J, Lanaghan K, MacDuff R, MacLeod M, McGlynn D, McMillan N, Murdoch L, Noble C, Paterson V, Steedman T, Tzemos N.Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial.Trials. 2012 Oct 4;13:184. doi: 10.1186/1745-6215-13-184.

Brown SP, Wang H, Aufderheide TP, Vaillancourt C, Schmicker RH, Cheskes S, Straight R, Kudenchuk P, Morrison L, Colella MR, Condle J, Gamez G, Hostler D, Kayea T, Ragsdale S, Stephens S, Nichol G; ROC Investigators.A randomized trial of continuous versus interrupted chest compressions in out-of-hospital cardiac arrest: Rationale for and design of the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial. Am Heart J. 2015 Mar;169(3):334-341.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-16 xiaoai5777

    好文字

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-15 hbwang006

    值得期待,好好看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-15 daniustone

    中国的临床研究什么时候可以牛起来

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-14 medcardio

    重量级研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-14 daniustone

    好文章

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=18406, encodeId=77ee184066a, content=好文字, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Mon Mar 16 20:20:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325015, encodeId=c3901325015c0, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Mar 16 00:33:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18355, encodeId=09421835564, content=值得期待,好好看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sun Mar 15 18:54:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18341, encodeId=04ab18341e3, content=中国的临床研究什么时候可以牛起来, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sun Mar 15 12:21:00 CST 2015, time=2015-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18301, encodeId=108b1830107, content=重量级研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Mar 14 11:44:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18285, encodeId=4f2318285bf, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dd21607321, createdName=daniustone, createdTime=Sat Mar 14 10:52:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18280, encodeId=0e7e1828034, content=都是心内科相关的, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=drhqh240, createdTime=Sat Mar 14 10:13:00 CST 2015, time=2015-03-14, status=1, ipAttribution=)]
    2015-03-14 drhqh240

    都是心内科相关的

    0

相关资讯

ACC 2015:地高辛增房颤患者死亡风险达27%

即将在美国心脏病学会年会(ACC 2015)公布的一项研究显示,房颤患者服用地高辛的全因死亡风险较未服用者高27%,心源性死亡风险高21%;而房颤合并肾衰的患者服用地高辛的风险更是比相似病情下、未服用者的死亡风险增加60%~70%。 使用地高辛以前就曾被认为与房颤患者死亡危险增加有关,2012年11月27日发表在《欧洲心脏杂志》上的一篇研究显示,地高辛使用者全因死亡率较未使用者增加41%。 美

AHA/ACC提出临床数据标准化定义

刀币、布币、环钱……,秦统一前各诸侯国的钱币可谓形态各异,这大大阻碍了当时的经济发展。当前,收集上来的临床数据也是凌乱的,同样羁绊了医学前进的脚步。 为了构建更为优良的数据环境,美国心脏病学院(ACC)/美国心脏协会(AHA)的临床数据标准工作组与美国食品药品管理局(FDA)和心血管试验标准数据采集联盟(SCTI)合作阐述了关于“为临床试验和健康相关研究制定通用语言迈步”的标准。

ACC 2015:住院早期利尿剂应答不佳与急性心衰患者转归较差(ASCEND-HF)

今天召开的美国心脏病学会年会(ACC2015)上发布的一项研究表明,急性心衰患者住院早期利尿剂应答不佳与血压较低、肾功能受损、尿量较少以及死亡在再住院风险升高具有相关性。奈西立肽对利尿剂应答影响呈中性。 急性心衰患者仍在继续应用奈西立肽。此项研究共纳入4379例急性心衰患者,并评估了从住院至入院后48小时的利尿剂应答,以及奈西立肽对入院早期利尿剂应答的影响。以每40mg呋塞米或等量利尿剂体重

ACC 2015:地中海饮食可使心脏病风险减半

全球心血管医生的学术盛会——美国心脏病学会年会(ACC 2015)将于3月14~16日在美国圣迭戈召开,届时中国医学论坛报的记者将亲赴前线,为您带来一手新鲜资讯。一项以年龄在18~89岁的2500名希腊成人为研究对象的研究表明,长期使用地中海饮食可显著降低心脏疾病风险。在该研究中,研究对象从2001年至2012年,每年向研究者提供自己的健康信息,通过对这些数据进行分析显示,长期食用地中海饮食的成人

ACC 2015:空气污染增颈动脉狭窄风险

全球心血管医生的学术盛会——美国心脏病学会年会(ACC2015)将于3月14~16日在美国圣迭戈召开。纽约大学Langone医学中心的一项研究显示,居住在空气污染更严重地区的居民发生颈动脉狭窄的风险更大。颈动脉狭窄与美国每年超过一半的卒中相关。该研究将在ACC2015中公布,并将同步发表于《美国心脏病学会杂志》(JACC)。已有研究显示,空气污染与心血管疾病相关,但大多数研究都集中在空气污染与心脏

ACC 2015:远离三大危险因素可延缓心衰发病

全球心血管医生的学术盛会——美国心脏病学会年会(ACC2015)将于3月14~16日在美国圣迭戈召开,届时中国医学论坛报的记者将亲赴前线,为您带来一手新鲜资讯。有哪些研究即将发布,我们先睹为快! ■远离三大危险因素,心衰发病将延缓11~13年 肥胖、高血压、糖尿病是心力衰竭的危险因素。根据西北大学(Northwestern University)Faraz Ahmad博士牵头的一项研究,与45